Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis
J Liu, G Zhang, L Yang, D Yan, J Yu, S Wei, J Li… - European Journal of …, 2024 - Elsevier
Background Salvage liver transplantation (SLT) is an effective treatment option for recurrent
hepatocellular carcinoma (rHCC) following primary curative treatment (CUR). However, its …
hepatocellular carcinoma (rHCC) following primary curative treatment (CUR). However, its …
Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma
B Pang, B Zuo, L Huang, X You, T Liu, J Hao… - International …, 2024 - Elsevier
Background Local treatment may function synergistically with immunotherapy and targeted
agents. This study aimed to assess the effectiveness and safety of transcatheter arterial …
agents. This study aimed to assess the effectiveness and safety of transcatheter arterial …
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
C Hou, B Xiong, L Zhou, Y Fei, C Shi, X Zhu, T Xie… - BMC cancer, 2024 - Springer
Background The safety and efficacy of transarterial chemoembolization plus molecular
targeted therapy (MTT) combined with immune checkpoint inhibitors (ICIs) in primary liver …
targeted therapy (MTT) combined with immune checkpoint inhibitors (ICIs) in primary liver …